SPARC

SUNPHARMAADVANCEDRESEARCHCOMPANY03 May 2024

Pharmaceuticals

₹

-11.85 (-4.99%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in SPARC

SPARC

Pharmaceuticals

SUNPHARMAADVANCEDRESEARCHCOMPANY03 May 2024

₹

-11.85 (-4.99%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
08-Mar-2016	R	5:116 Rights Issue of Equity Shares SUB. :- Rights issue of Equity Shares of Sun Pharma Advanced Research Company Ltd. (Scrip Code 532872) Trading Members of the Exchange are hereby informed that, Sun Pharma Advanced Research Company Ltd. has fixed the Record date for the purpose of Rights Issue of Equity Shares. The transactions in the equity shares of the Company should be done on ex-rights basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Sun Pharma Advanced Research Company Ltd. (532872, 632872) RECORD DATE 17/03/2016 PURPOSE Issue of 5 (FIVE) equity shares of Re. 1/- each for cash at premium of Rs 244/- per share on rights basis for every 116 (ONE HUNDRED AND SIXTEEN) equity shares of Re. 1/- each held. Ex-Right basis from Date & Sett. No. 16/03/2016 DR-240/2015-2016 Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated on 09.03.2016)	17-Mar-2016	5:116
24-Jan-2024	BC	SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2024 inter alia to consider and approve The Unaudited financi	05-Feb-2024
27-Oct-2023	BC	SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 inter alia to consider and approve Board Meeting Intimat	06-Nov-2023
22-Sep-2023	BC	Intimation for Appointment of Company Secretary & Compliance Officer and Key Managerial Personnel of the Company.	22-Sep-2023
07-Aug-2023	BC	As per the attachment Change in Key Managerial Personnel. (As per BSE Announcement Dated on 11/09/2023)	11-Sep-2023
12-Jul-2023	BC	AGM 07/08/2023 The 18th Annual General Meeting of the Company will be held on Monday, August 07, 2023 at 03:30 PM (IST) through Video Conferencing / Other Audio Visual Means. Newspaper advertis	07-Aug-2023

Record Date01 Jan'1900

Ex-Rights Date01 Jan'1900

Premium(Rs.)244

Ratio5:116

Book Closure

Record Date	Split Date	Purpose
05-Feb-2024	-	SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2024 inter alia to consider and approve The Unaudited financi
06-Nov-2023	-	SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 inter alia to consider and approve Board Meeting Intimat
22-Sep-2023	-	Intimation for Appointment of Company Secretary & Compliance Officer and Key Managerial Personnel of the Company.
11-Sep-2023	-	As per the attachment Change in Key Managerial Personnel. (As per BSE Announcement Dated on 11/09/2023)
07-Aug-2023	-	AGM 07/08/2023 The 18th Annual General Meeting of the Company will be held on Monday, August 07, 2023 at 03:30 PM (IST) through Video Conferencing / Other Audio Visual Means. Newspaper advertis

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Sun Pharma Advanced Research Company Ltd ₹225.50(-11.85/-4.99%)	225.50	-11.85	7,317.96	15.37	0.00	22.07
Lupin Ltd ₹1,654.75(+7.10/0.43%)	1,654.75	+7.10	75,415.25	133.18	36.60	3.91
Ipca Laboratories Ltd ₹1,337.70(-13.30/-0.98%)	1,337.70	-13.30	33,938.01	88.94	61.57	5.46
J B Chemicals & Pharmaceuticals Ltd ₹1,889.90(+4.30/0.23%)	1,889.90	+4.30	29,330.27	80.31	57.90	10.92
Sanofi India Ltd ₹8,624.25(-53.50/-0.62%)	8,624.25	-53.50	19,861.65	59.17	33.61	19.54
IOL Chemicals & Pharmaceuticals Ltd ₹395.55(+3.25/0.83%)	395.55	+3.25	2,322.10	-0.40	13.44	1.46

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	13.86	21.18	23.95	47.69	131.09	31.54
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	13.86	21.18	23.95	47.69	131.09	31.54
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	6.39	8.49	10.19	10.73	0.03	0.06
Total Income	20.25	29.67	34.14	58.42	131.12	31.60
Total Expenditure	116.48	112.65	126.13	137.26	114.91	94.14
PBIDT	-96.23	-82.98	-91.99	-78.84	16.21	-62.54
Interest	0.26	0.26	0.26	0.21	2.93	2.86
PBDT	-96.49	-83.24	-92.25	-79.05	13.28	-65.40
Depreciation	3.16	3.18	3.10	2.94	3.13	3.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-99.65	-86.42	-95.35	-81.99	10.15	-68.40
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-99.65	-86.42	-95.35	-81.99	10.15	-68.40

EPS (Unit Curr.)	-3.07	-2.66	-2.94	-2.55	0.37	-2.52
EPS (Adj) (Unit Curr.)	-3.07	-2.66	-2.94	-2.55	0.37	-2.52
Calculated EPS (Unit Curr.)	-3.07	-2.66	-2.94	-2.53	0.37	-2.52
Calculated EPS (Adj) (Unit Curr.)	-3.07	-2.66	-2.94	-2.53	0.37	-2.52
Calculated EPS (Ann.) (Unit Curr.)	-12.28	-10.65	-11.75	-10.11	1.47	-10.06
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-12.28	-10.65	-11.75	-10.11	1.47	-10.06
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	32.45	32.45	32.45	32.45	27.53	27.19
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00	1.00	1.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-694.30	-391.78	-384.09	-165.32	12.37	-198.29
PBDTM(%)	-696.18	-393.01	-385.18	-165.76	10.13	-207.36
PATM(%)	-718.98	-408.03	-398.12	-171.92	7.74	-216.87

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	32.45	27.19	26.21	26.21	26.21	25.09
Reserves Total	480.32	-230.22	-194.46	-44.84	270.03	159.63
Equity Share Warrants	0.00	234.26	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	512.77	31.23	-168.25	-18.63	296.24	184.72
Secured Loans	0.05	75.00	150.00	5.83	0.00	0.00
Unsecured Loans	15.62	4.21	86.38	61.09	1.64	2.28
Total Debt	15.67	79.21	236.38	66.92	1.64	2.28
Total Liabilities	528.44	110.44	68.13	48.29	297.88	187.00
APPLICATION OF FUNDS :
Gross Block	146.22	133.15	122.51	135.50	80.22	67.17
Less : Accumulated Depreciation	40.47	41.28	31.95	31.64	22.66	15.44
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	105.75	91.87	90.56	103.86	57.56	51.73
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	27.00	26.37	5.23	32.07	24.13	3.27
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	290.90	11.66	6.43	8.49	210.58	107.57
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.00	0.00	0.00	0.00	0.00
Sundry Debtors	32.71	27.74	17.58	16.05	10.17	17.56
Cash and Bank	111.58	1.23	9.31	0.46	0.68	1.32
Loans and Advances	19.77	30.53	29.80	42.19	35.96	48.77
Total Current Assets	164.06	59.49	56.69	58.70	46.81	67.66
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	169.40	89.37	107.94	169.50	90.04	111.36
Provisions	6.49	5.28	5.75	5.31	4.46	4.10
Total Current Liabilities	175.89	94.65	113.69	174.81	94.50	115.46
Net Current Assets	-11.83	-35.16	-57.00	-116.11	-47.69	-47.80
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	411.82	94.73	45.22	28.31	244.57	114.77
Contingent Liabilities	197.21	197.21	188.09	185.98	175.29	122.17

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	1.22	9.30	0.35	0.35	0.20
Net Cash from Operating Activities	-69.12	-208.23	-151.90	-210.81	-171.91
Net Cash Used In Investing Activities	-548.28	-29.17	1.56	155.35	-102.19
Net Cash Used In Financing Activities	616.76	229.32	159.28	55.46	274.25
Net Inc./Dec In Cash And Cash Equivalents	-0.64	-8.08	8.95	0.00	0.15
Cash And Cash Equivalents At End Of The Year	0.58	1.22	9.30	0.35	0.35

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

65.67%

FII Shareholding

3.23%

DII Shareholding

0.82%

Public Shareholding

30.28%

**Promoter pledged shareholding 65.67%

About Sun Pharma Advanced Research Company Ltd

Sun Pharma Advanced Research Company Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 7321.21 crores. It has reported a sales of Rs. 13.86 crores and a net profit of Rs. -99.65 crores for the quarter ended December 2018. The company management includes Dilip S Shanghvi, T Rajamannar,Sudhir V Valia,Bhavna Doshi,Ferzaan Engineer,Robert Spiegel,Dilip S Shanghvi (Sun Pharma Advanced Research Company Ltd) among others.

Chairman

Dilip S Shanghvi

Registered office

Sun Pharma Advanced Res Centre,Akota Road Akota,Vadodara,Gujarat,390020

FAX :91-265-2354897

Background

Incorporation Year2006

Face Value₹1

Market Lot1

How to buy SPARC shares on nse?

To buy SPARC shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the SPARC share price today?

The SPARC shares price on nse is Rs.225.5 today.

What is the market cap of SPARC shares on NSE ?

The company has a market capitalization of Rs.7317.96Cr

What is the PE & PB ratio of SPARC shares ?

PE is 0 and PB is 22.07

What is the 52 Week High and Low of SPARC shares?

SPARC stock price high: Rs.472.8 SPARC stock price low: Rs.178.8